REFRACTORY ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE
Clinical trials for REFRACTORY ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE trials appear
Sign up with your email to follow new studies for REFRACTORY ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for babies with aggressive leukemia: targeted drug trial underway
Disease control OngoingThis study is testing whether adding a new oral drug called revumenib to standard chemotherapy is safe and effective for infants and young children with a specific, high-risk type of leukemia that has come back or hasn't responded to previous treatments. The trial aims to find th…
Matched conditions: REFRACTORY ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
New hope for kids with Tough-to-Treat leukemia: experimental combo enters testing
Disease control OngoingThis study is testing a new combination of oral drugs (selinexor and venetoclax) with standard chemotherapy for children and young adults whose acute myeloid leukemia (AML) has returned or hasn't responded to previous treatments. The main goal is to find the safest and most effec…
Matched conditions: REFRACTORY ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Mar 10, 2026 12:52 UTC